Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 161

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Guidelines on the laboratory aspects of assays used in haemostasis and thrombosis

Open access
Mackie, I., Cooper, P., Lawrie, A., Kitchen, S., Gray, E., Laffan, M., British Committee for Standards in Haematology·2013·International Journal of Laboratory Hematology

Abstract

Publications known to the writing group were supplemented with additional papers identified by searching Medline/PubMed for publications in the last 12 years using keywords: coagulation assays, amidolytic assays, haemostasis assays, and thrombophilia testing, in core clinical journals and English language. Additional relevant articles were identified by screening reference lists and by publications known to the writing group. The writing group produced the draft guideline which was subsequently revised by consensus by members of the Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology (BCSH). The guideline was then reviewed by a sounding board of approximately 50 UK haematologists, BCSH and the British Society for Haematology committee and comments incorporated where appropriate. The 'GRADE' system does not apply (because clinical trials are not available to support the 'best practice' recommendations that have been generated) and was therefore not used. This guideline is intended to help clinical laboratories perform valid and reliable assays of pro- and anticoagulant factors in blood. Guidance on lupus anticoagulant (LA) testing, fibrinogen assays, D-dimer assays, platelet function tests, von Willebrand factor assays and anticoagulant monitoring is available in other BCSH and UKHCDO documents (www.bcshguidelines.com; www.ukhcdo.org/UKHCDOguidelines.htm). Clinical guidelines on thrombophilia, haemophilia and other bleeding disorders are also available from these bodies and should be used in conjunction with these laboratory guidelines. Global assays of coagulation such as thrombelastography or thrombin generation will not be considered here. The requirements for blood collection, handling and storage have been discussed in detail elsewhere 1-3, but key points are summarized as recommendations in Table 1. Particular attention is drawn to the correct filling of tubes containing the appropriate anticoagulant and the effects of high haematocrit. Many tests used to assess haemostasis can be influenced by medication and this must be taken into account. Coagulation screening tests such as prothrombin time (PT) and activated partial thromboplastin time (APTT) may provide useful information (particularly when full clinical details are not available) which can help to avoid problems in the interpretation of coagulation assay results (e.g. anticoagulant effects or the presence of coagulopathy). Haemolysis can affect some tests of haemostasis, either because of the presence of thromboplastic substances or interference of haemoglobin pigment with photo-optical systems. For example, the APTT can be shortened and antithrombin (AT) decreased by in vitro haemolysis 4. Where in vitro haemolysis has occurred, such samples should not be tested. Gross icterus and lipaemia may also affect analysers, by interfering with optical absorbance or impeding light transmittance. Rheumatoid factor and anti-mouse antibodies may produce erroneous results in immunoassays 5, 6. Whenever possible, normal reference ranges should be established locally with an appropriate number of healthy normal subjects; apparently normal patients should be excluded, as they may be subject to stress which influences certain haemostasis proteins. A minimum number of 120 subjects have been recommended for establishing reference intervals 7. Some authors suggest that a close approximation can be obtained by testing at least 30 normal subjects 8, but with groups <50, the values defining the reference interval have a confidence interval wider than the standard deviation of the observations 9. The reference interval may vary for different reagent and analyser combinations and for some analytes, age, sex and blood group should be considered in the interpretation. Specific and separate intervals are required for paediatric populations 10, 11. Coagulation end-point assays are bioassays used for estimating the concentration of individual blood coagulation factors within a test sample. The concentration is determined relative to a standard or reference preparation (that has itself been calibrated against a standard), by assessing the degree to which dilutions of those preparations (i.e. the standard and the test) correct the coagulation time of a substrate plasma specifically deficient in the factor, in a suitable test system (e.g. PT or APTT). A linear portion of the dose response curve should be determined for each set of reagents by testing a wide range of normal plasma dilutions (e.g. serial doubling dilutions 1/2–1/1024, plus a buffer blank to determine the maximal coagulation time). At least two dilution sets should be made independently to avoid systematic error. This process produces a classical sigmoid dose–response curve with a central linear component (Figure 1a). The differences between plasma dilutions in the series selected for an assay should be as large as possible (i.e. twofold, threefold, fourfold, etc. dilutions)

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/ijlh.12004

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 161

Metadata

Authors
Mackie, I., Cooper, P., Lawrie, A., Kitchen, S., Gray, E., Laffan, M., & British Committee for Standards in Haematology
Venue
International Journal of Laboratory Hematology
Publisher
Wiley
Published
2012-09-17
Volume
35
Issue
1
Pages
1-13
ISSN
  • 1751-5521 (ISSN-L)
  • 1751-553X
OpenAlex
W2002116184
Cited by
161
References
1
FWCI
5.76
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Guidelines on the laboratory aspects of assays used in haemostasis and thrombosis. https://app.cochat.ai/papers/10.1111/ijlh.12004
The paper
Mackie, I., Cooper, P., Lawrie, A., Kitchen, S., Gray, E., Laffan, M., & British Committee for Standards in Haematology. (2013). Guidelines on the laboratory aspects of assays used in haemostasis and thrombosis. International Journal of Laboratory Hematology. https://doi.org/10.1111/ijlh.12004

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.